THE

DOSE

Daily news for smarter treatment decisions.

Latest Stories

FDA regulation updates for GLP-1 drugs

FDA Holds Public Hearing on the Fast-Track Program That Approved Foundayo

FDA sought public feedback on the Priority Voucher program that enabled the record 50-day approval of Eli Lilly's GLP-1 pill Foundayo.

The Dose·Jun 4, 2026

FDA Moves to End Cheap GLP-1 Compounding Era: Permanent Exclusion Proposed

By The Dose

FDA regulation updates for GLP-1 drugs

FDA Proposes to Block Large-Scale GLP-1 Compounding in Major Access Shift

By The Dose

Editorial cartoon: person walking through doorway on abstract shapes

FDA Plans July Meeting to Ease Peptide Restrictions After RFK Jr. Push

By RC Nelson

Editorial cartoon: shield with check mark on green waves

Editorial cartoon: scroll/document on navy/teal waves

AI-Powered GLP-1 Telehealth Giant MEDVi Faces FDA Warnings and Lawsuits

By GLP1 Clinics News Desk·Apr 7, 2026

Editorial cartoon: trending up arrow on teal/yellow waves

Four States Drop GLP-1 Obesity Coverage as Federal Expansion Model Launches

By RC Nelson·Mar 27, 2026

Editorial cartoon: scroll/document on navy/teal waves

CMS Launches BALANCE Model to Expand GLP-1 Access in Medicare and Medicaid

By GLP1 Clinics News Desk·Mar 24, 2026

Showing 3 of 7 articles.